Stockreport

Immunic Conference: “Transformative” 2026 Ahead With Pivotal MS Data Due Late Year, NDA Next [Yahoo! Finance]

Immunic, Inc.  (IMUX) 
PDF in the year and is preparing for an NDA submission the following year after recently raising capital. Vidofludimus calcium is positioned as a dual-mechanism oral thera [Read more]